German molecular Dx company obtains $16.3M in financing

04/23/2013 | GenomeWeb Daily News (free registration)

Curetis has raised $16.3 million in Series B financing, which it will use to support its operational and commercial expansion. The Germany-based firm plans to submit an FDA 510(k) clearance application next year for its Unyvero system, a DNA-based diagnostics platform that can detect multiple antibiotic-resistant organisms and bacteria from a single sample in one go.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA